Rightsmile Inc (RIGH) 0.0001 $RIGH Will Big Tobacco

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Rightsmile Inc (RIGH) 0.0001 $RIGH

Will Big Tobacco Become Big Marijuana? USA Today Asks; Bud Genius Answers
BusinessWire - Thu Apr 16, 7:37AM CDT
Bud Genius, Inc. (www.bgmedtech.com) (OTC: RIGH), a leading laboratory for cannabis testing and profiling, developer of data-driven rating systems for marijuana strains, brand and retail development specialist, and licensee of celebrity-endorsed marijuana-related merchandise, commented today on an article in USA Today, which examined the potential role of major tobacco companies in the cannabis industry.

Bud Genius Announces Intention to Repurchase More Company Shares
BusinessWire - Thu Apr 09, 7:37AM CDT
Bud Genius, Inc. (www.bgmedtech.com) (OTC: RIGH), a leading laboratory for cannabis testing and profiling, developer of data-driven rating systems for marijuana strains, brand and retail development specialist, and licensee of celebrity-endorsed marijuana and hemp related merchandise, announced today that the company is considering a share repurchase of up to 2 billion shares.

Bud Genius Announces Important Addition to Advisory Board
BusinessWire - Thu Apr 02, 7:37AM CDT
Bud Genius, Inc. (OTC: RIGH), a leading laboratory for cannabis testing and profiling, developer of data-driven rating systems for marijuana strains, brand and retail development specialist, and licensee of celebrity-endorsed marijuana and hemp related merchandise, announced today an addition to their Executive Advisory Board.

Bud Genius Announces LOI to Acquire Evergreen Licensing - an Exclusive Licensor of Tommy Chong Products
BusinessWire - Mon Mar 30, 7:37AM CDT
Bud Genius, Inc. (www.bgmedtech.com) (OTC: RIGH), a leading laboratory for cannabis testing and profiling, developer of data-driven rating systems for marijuana strains, brand and retail development specialist, and licensee of celebrity-endorsed marijuana and hemp related merchandise, announced today they have signed a Letter of Intent to acquire Evergreen Licensing - exclusive licensor of Tommy Chong marijuana, hemp, and cannabis-related products.

Bud Genius Provides Solution to Major Flaw in Medical Marijuana Industry
BusinessWire - Thu Mar 19, 7:37AM CDT
Bud Genius, Inc. (www.BGMedtech.com) (OTC: RIGH), a leading laboratory for cannabis testing and profiling, developer of data-driven rating systems for marijuana strains, brand and retail development specialist, and licensee of celebrity-endorsed marijuana and hemp related merchandise, commented today on a recent article in Mother Nature Network, listing over a dozen ailments that cannabis has been shown to help.

Bud Genius Adds Leading Cannabis Marketing Pro to Lead Company Communications Programs
BusinessWire - Mon Mar 16, 7:37AM CDT
Bud Genius, Inc. (www.bgmedtech.com) (OTC: RIGH), a leading laboratory for cannabis testing and profiling, developer of data-driven rating systems for marijuana strains, brand and retail development specialist, and licensee of celebrity-endorsed marijuana and hemp related merchandise, announced today they have added Randall A. Huft, noted cannabis marketing and communications expert, to their Executive Team.

Bud Genius Launches New Investor Relations Website
BusinessWire - Thu Mar 12, 7:37AM CDT
Bud Genius, Inc. (www.BGMedTech.com) (OTC: RIGH), a leading laboratory for cannabis testing and profiling, developer of data-driven rating systems for marijuana strains, brand and retail development specialist, and licensee of celebrity-endorsed marijuana and hemp related merchandise, announced today the launch of their new Investor Relations Website.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Palisade Bio Launches PALI-2108 Study to Combat Crohn’s Disease

Updated Category News Views 142

Exciting Developments in Crohn’s Disease Treatment Today marks a pivotal point as Palisade Bio, Inc. (NASDAQ: PALI), a dynamic clinical-stage biopharmaceutical firm, undertakes a groundbreaking step in medical research by announcing the commencement of patient dosing in their Phase 1b clinical trial. This study is focused on PALI-2108, a novel therapeutic designed...

Continue Reading
Discover How Your $100 Investment in TD Synnex Has Grown

Updated Category News Views 126

Understanding the Growth of Your Investment in TD Synnex Investing in stocks can often feel like navigating a complex maze, especially when evaluating potential growth over time. One standout in the tech industry is TD Synnex (NASDAQ: SNX), a company that has consistently outperformed benchmark indices. Over the past five years, TD Synnex has achieved an annualized return...

Continue Reading
Castor Maritime Inc. Completes Successful Sale and Leaseback

Updated Category News Views 170

Castor Maritime Inc. Completes Successful Sale and Leaseback Castor Maritime Inc. (NASDAQ: CTRM), a versatile player in the global shipping and energy sector, recently announced an exciting development. The company successfully concluded a significant sale and leaseback transaction for its vessel, the M/V Magic Thunder, an impressive Kamsarmax bulk carrier that was built...

Continue Reading
Yamaha's Partnership with Locally Enhances Dealer Collaboration

Updated Category News Views 153

Yamaha Expands Dealer Network with Innovative Omnichannel Solutions Yamaha, a renowned global leader in musical instruments and audio solutions, has recently announced a strategic partnership with Locally. This collaboration aims to elevate the shopping experience for consumers and to strengthen relationships with local retailers. This initiative is particularly...

Continue Reading
POET Technologies Celebrates AI Award Win at Global Tech Awards

Updated Category News Views 73

POET Technologies' Landmark Achievement in Artificial Intelligence POET Technologies Inc. (TSX Venture: PTK; NASDAQ: POET), known for its groundbreaking work with the POET Optical Interposer™, has recently been honored with the title of "Best in Artificial Intelligence" at the Global Tech Awards 2024. This prestigious recognition was announced following the awards...

Continue Reading